• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人类abl基因和bcr-abl融合基因转录的RNA的可变剪接。

Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.

作者信息

Shtivelman E, Lifshitz B, Gale R P, Roe B A, Canaani E

出版信息

Cell. 1986 Oct 24;47(2):277-84. doi: 10.1016/0092-8674(86)90450-2.

DOI:10.1016/0092-8674(86)90450-2
PMID:3021337
Abstract

The primary structure of normal abl protein was determined by sequencing the coding region of its cDNA. abl contains two alternative 5' exons spliced to a common set of 3' exons to yield the two major abl RNA transcripts. These transcripts initiate in different promoter regions and give rise to proteins that vary in their N-termini. In the human cell line K562, abl is translocated from chromosome 9 to within the bcr gene on chromosome 22. Within the fused bcr-abl gene, abl exon II alternatively splices to two adjacent bcr exons. This phenomenon is seen in many patients with chronic myeloid leukemia.

摘要

通过对正常abl蛋白cDNA编码区进行测序,确定了其一级结构。abl含有两个可变的5'外显子,它们与一组共同的3'外显子拼接,产生两种主要的abl RNA转录本。这些转录本在不同的启动子区域起始,并产生N端不同的蛋白质。在人细胞系K562中,abl从9号染色体易位至22号染色体上的bcr基因内。在融合的bcr-abl基因中,abl外显子II可选择性地与两个相邻的bcr外显子拼接。这种现象在许多慢性髓性白血病患者中都可见到。

相似文献

1
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.从人类abl基因和bcr-abl融合基因转录的RNA的可变剪接。
Cell. 1986 Oct 24;47(2):277-84. doi: 10.1016/0092-8674(86)90450-2.
2
Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.abl癌基因的激活及其在人类白血病染色体易位中的作用。
Mutat Res. 1988 May;195(3):231-43. doi: 10.1016/0165-1110(88)90002-4.
3
Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.
Mutat Res. 1987 Sep;186(2):161-72. doi: 10.1016/0165-1110(87)90029-7.
4
Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.人类ABL基因、BCR基因以及参与费城染色体易位的区域的序列与分析。
Genomics. 1995 May 1;27(1):67-82. doi: 10.1006/geno.1995.1008.
5
Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病中bcr和c-abl基因的独特融合
Cell. 1987 Oct 9;51(1):33-40. doi: 10.1016/0092-8674(87)90007-9.
6
Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.慢性髓性白血病(CML)中一种变异的费城染色体1易位t(9;22;11) (q34;q11;q13)的分子特征显示,BCR基因的3'端部分易位至染色体带11q13。 1 费城染色体(Philadelphia chromosome,Ph)是一种特异性染色体异常,在慢性髓性白血病中常见。
Oncogene. 1993 Dec;8(12):3239-47.
7
Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.慢性粒细胞白血病患者费城染色体阳性B淋巴细胞系中易位c-abl癌基因的可变表达。
Proc Natl Acad Sci U S A. 1986 Jun;83(11):4049-52. doi: 10.1073/pnas.83.11.4049.
8
bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.bcr/abl和src而非myc和ras在淋巴样转化中取代了v-abl。
Mol Cell Biol. 1990 Aug;10(8):4365-9. doi: 10.1128/mcb.10.8.4365-4369.1990.
9
Structural organization of the bcr gene and its role in the Ph' translocation.bcr基因的结构组织及其在费城染色体易位中的作用。
Nature. 1985;315(6022):758-61. doi: 10.1038/315758a0.
10
Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia.对源自一名人类T细胞白血病患者的含t(7;9)的细胞系(SUP-T3)中的TCRB和ABL进行分子分析。
Proc Natl Acad Sci U S A. 1987 Jan;84(1):251-5. doi: 10.1073/pnas.84.1.251.

引用本文的文献

1
A survey on deep learning for drug-target binding prediction: models, benchmarks, evaluation, and case studies.关于用于药物-靶点结合预测的深度学习的综述:模型、基准测试、评估及案例研究
Brief Bioinform. 2025 Aug 31;26(5). doi: 10.1093/bib/bbaf491.
2
The regulations of telomerase reverse transcriptase (TERT) in cancer.端粒酶逆转录酶(TERT)在癌症中的调控
Cell Death Dis. 2024 Jan 26;15(1):90. doi: 10.1038/s41419-024-06454-7.
3
The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia.HIF1α在慢性髓性白血病中的分子作用得到阐明。
Front Oncol. 2022 Jun 30;12:912942. doi: 10.3389/fonc.2022.912942. eCollection 2022.
4
Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation.慢性髓性白血病联合疗法实现潜在无治疗缓解:聚焦白血病干细胞与免疫调节
Front Oncol. 2021 May 13;11:643382. doi: 10.3389/fonc.2021.643382. eCollection 2021.
5
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges.血液系统恶性肿瘤中Yes相关蛋白信号通路的新见解:诊断和治疗挑战
Cancers (Basel). 2021 Apr 20;13(8):1981. doi: 10.3390/cancers13081981.
6
Fusion transcripts: Unexploited vulnerabilities in cancer?融合转录本:癌症未被开发的弱点?
Wiley Interdiscip Rev RNA. 2020 Jan;11(1):e1562. doi: 10.1002/wrna.1562. Epub 2019 Aug 13.
7
Human BCR/ABL1 induces chronic myeloid leukemia-like disease in zebrafish.人 BCR/ABL1 可诱导斑马鱼罹患慢性髓性白血病样疾病。
Haematologica. 2020 Mar;105(3):674-686. doi: 10.3324/haematol.2019.215939. Epub 2019 Jul 9.
8
Response to Imatinib therapy is inferior for e13a2 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia.在慢性髓性白血病中,与e14a2转录本类型相比,伊马替尼治疗对e13a2转录本类型的反应较差。
BMC Hematol. 2019 May 2;19:7. doi: 10.1186/s12878-019-0139-2. eCollection 2019.
9
The Impact of Next-Generation Sequencing on Cancer Genomics: From Discovery to Clinic.下一代测序技术对癌症基因组学的影响:从发现到临床。
Cold Spring Harb Perspect Med. 2019 Sep 3;9(9):a036269. doi: 10.1101/cshperspect.a036269.
10
Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir.伊马替尼治疗的慢性髓性白血病(CML)中BCR-ABL融合转录本变体的预后意义。克什米尔CML患者的同类首项研究。
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1479-1485. doi: 10.22034/APJCP.2018.19.6.1479.